145 related articles for article (PubMed ID: 4875170)
1. A three-year trial of atromid therapy in exudative diabetic retinopathy.
Duncan LJ; Cullen JF; Ireland JT; Nolan J; Clarke BF; Oliver MF
Diabetes; 1968 Jul; 17(7):458-67. PubMed ID: 4875170
[No Abstract] [Full Text] [Related]
2. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
Cullen JF; Ireland JT; Oliver MF
Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
[No Abstract] [Full Text] [Related]
3. Treatment of exudative diabetic retinopathy with atromid-S.
Houtsmuller AJ
Ophthalmologica; 1968; 156(1):2-5. PubMed ID: 4876848
[No Abstract] [Full Text] [Related]
4. [Action mechanism and clinical success of Regelan (Clofibrate)].
Fitzgerald JD
Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
[No Abstract] [Full Text] [Related]
5. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
Vannas S; Esilä R; Tuovinen E
Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
[No Abstract] [Full Text] [Related]
6. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
Engström J
Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263
[No Abstract] [Full Text] [Related]
7. [The treatment of exudative diabetic retinopathies with clofibrate (Atromid-S)].
Houtsmuller AJ
Ned Tijdschr Geneeskd; 1967 Nov; 111(45):2039-40. PubMed ID: 4863523
[No Abstract] [Full Text] [Related]
8. Atromid-S for the reduction of plasma lipids.
Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
[No Abstract] [Full Text] [Related]
9. Atromid and platelet adhesiveness in multiple sclerosis.
Millac P; Caspary EA; Prineas J
J Atheroscler Res; 1967; 7(3):397-400. PubMed ID: 5340971
[No Abstract] [Full Text] [Related]
10. The treatment of diabetic retinopathy.
Cullen JF
Geriatrics; 1968 Jul; 23(7):137-48. PubMed ID: 5661095
[No Abstract] [Full Text] [Related]
11. Laboratory indices in clofibrate therapy of juvenile-onset diabetes.
Narduzzi JV; Danowski TS; Weir TF; Alley RA; Vester JW; Moses C
Clin Pharmacol Ther; 1967; 8(6):817-23. PubMed ID: 4862480
[No Abstract] [Full Text] [Related]
12. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
[No Abstract] [Full Text] [Related]
13. [Clinical-experimental studies on lipid metabolism using Regelan].
Hammerl H
Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
[No Abstract] [Full Text] [Related]
14. Trial of "Atheran" and "Atromid-S" in atherosclerosis.
Barnett AJ; Carson V
Med J Aust; 1966 Jun; 1(23):965-70. PubMed ID: 5939995
[No Abstract] [Full Text] [Related]
15. A comparison of platelet stickiness tests during an atromid-S trial.
O'Brien JR; Heywood JB
Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
[No Abstract] [Full Text] [Related]
16. [Atromid].
Borchgrevink CF
Tidsskr Nor Laegeforen; 1967 Mar; 87(5):334. PubMed ID: 6039533
[No Abstract] [Full Text] [Related]
17. Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus.
Danowski TS; Novak JF; Saul RW; Vester JW; Moses C
Clin Pharmacol Ther; 1966; 7(5):631-8. PubMed ID: 5957168
[No Abstract] [Full Text] [Related]
18. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
Schatz IJ
Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
[No Abstract] [Full Text] [Related]
19. Communications. Action of Atromid-S (clofibrate) on intra-ocular pressure.
Gloster J; Hartley RE; Perkins ES
Br J Ophthalmol; 1968 Nov; 52(11):793-800. PubMed ID: 4972749
[No Abstract] [Full Text] [Related]
20. [Effect of Atromid on blood lipids in patients with hyperlipemia].
Baranova LV
Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
